Microbiomarkers in inflammatory bowel diseases: Caveats come with caviar

Gut

Volumn 66, Issue 10, 2017, Pages 1734-1738

  Sommer, Felix ^a   Rühlemann, Malte Christoph ^a   Bang, Corinna ^a   Höppner, Marc ^a   Rehman, Ateequr ^a   Kaleta, Christoph ^a   Schmitt Kopplin, Phillippe ^b   Dempfle, Astrid ^c   Weidinger, Stephan ^c   Ellinghaus, Eva ^a   Krauss Etschmann, Susanne ^a,d   Schmidt Arras, DIrk ^a   Aden, Konrad ^a   Schulte, Dominik ^c   Ellinghaus, David ^a   Schreiber, Stefan ^a,c   Tholey, Andreas ^a   Rupp, Jan ^e   Laudes, Matthias ^c   Baines, John F ^a,f   Rosenstiel, Philip ^a   Franke, Andre ^a   more..

^a UNIVERSITY OF KIEL   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d RESEARCH CENTER BORSTEL   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

^f MAX PLANCK INSTITUTE FOR EVOLUTIONARY BIOLOGY   (Germany)

Author keywords

Biostatistics; Crohn's Disease; Intestinal Microbiology

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; RNA 16S;

ARTICLE; BACTERIAL LOAD; CHRONIC INFLAMMATION; CROHN DISEASE; DISEASE ACTIVITY; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; GENE SEQUENCE; HOST PATHOGEN INTERACTION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; METABOLOMICS; MICROBIAL DIVERSITY; NONHUMAN; PRIORITY JOURNAL; ULCERATIVE COLITIS; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

BIOMARKERS; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 85029306887     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-313678     Document Type: Article

References (41)

1. Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol 2016;14:e1002533.
2. Sommer F, Bäckhed F. Know your neighbor: Microbiota and host epithelial cells interact locally to control intestinal function and physiology. Bioessays 2016;38:455-64.
3. Franzosa EA, Huang K, Meadow JF, et al. Identifying personal microbiomes using metagenomic codes. Proc Natl Acad Sci USA 2015;112:E2930-E2938.
4. Falony G, Joossens M, Vieira-Silva S, et al. Populationlevel analysis of gut microbiome variation. Science 2016;352:560-4.
5. Wang J, Thingholm LB, Skieceviien J, et al. Genomewide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nat Genet 2016;48:1396-406.
6. Hamilton MJ, Weingarden AR, Unno T, et al. High-throughput DNA sequence analysis reveals stable engraftment of gut Microbiota following transplantation of previously frozen fecal Bacteria. Gut Microbes 2013;4:125-35.
7. Li SS, Zhu A, Benes V, et al. Durable coexistence of donor and recipient strains after fecal Microbiota transplantation. Science 2016;352:586-9.
8. Manichanh C, Reeder J, Gibert P, et al. Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res 2010;20:1411-9.
9. Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal Microbiota transplantation for active ulcerative colitis: A randomised placebocontrolled trial. Lancet 2017;389:1218-28.
10. Smirnov KS, Maier TV, Walker A, et al. Challenges of metabolomics in human gut Microbiota research. Int J Med Microbiol 2016;306:266-79.
11. Zhao L. The gut Microbiota and obesity: From correlation to causality. Nat Rev Microbiol 2013;11:639-47.
12. Saraswati S, Sitaraman R. Aging and the human gut microbiota-from correlation to causality. Front Microbiol 2014;5:764.
13. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal Microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006;55:205-11.
14. Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004;53:685-93.
15. Sommer F, Anderson JM, Bharti R, et al. The resilience of the intestinal Microbiota influences health and disease. Nat Rev Microbiol 2017.
16. Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset crohn's disease. Cell Host Microbe 2014;15:382-92.
17. Halfvarson J, Brislawn CJ, Lamendella R, et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat Microbiol 2017;2:17004.
18. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002;122:44-54.
19. Sommer F, Bäckhed F. The gut microbiota-masters of host development and physiology. Nat Rev Microbiol 2013;11:227-38.
20. Desai MS, Seekatz AM, Koropatkin NM, et al. A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility. Cell 2016;167:e21:1339-53.
21. Sonnenburg ED, Smits SA, Tikhonov M, et al. Dietinduced extinctions in the gut Microbiota compound over generations. Nature 2016;529:212-5.
22. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014;505:559-63.
23. Earle KA, Billings G, Sigal M, et al. Quantitative Imaging of Gut Microbiota spatial Organization. Cell Host Microbe 2015;18:478-88.
24. Sonnenburg ED, Sonnenburg JL. Starving our microbial self: The deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab 2014;20:779-86.
25. Lee T, Clavel T, Smirnov K, et al. Oral versus intravenous iron replacement therapy distinctly alters the gut Microbiota and metabolome in patients with IBD. Gut 2017;66:863-71.
26. Rampelli S, Schnorr SL, Consolandi C, et al. Metagenome sequencing of the Hadza Hunter-Gatherer Gut Microbiota. Curr Biol 2015;25:1682-93.
27. Schnorr SL, Candela M, Rampelli S, et al. Gut microbiome of the Hadza hunter-gatherers. Nat Commun 2014;5:3654.
28. Häsler R, Sheibani-Tezerji R, Sinha A, et al. Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease. Gut 2016:gutjnl-2016-311651.
29. Pascal V, Pozuelo M, Borruel N, et al. A microbial signature for crohn's disease. Gut 2017;66:813-22.
30. Gisbert JP, McNicholl AG. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis 2009;41:56-66.
31. Moum B, Ekbom A, Vatn MH, et al. Inflammatory bowel disease: Re-evaluation of the diagnosis in a prospective population based study in south eastern Norway. Gut 1997;40:328-32.
32. Harvey RF, Bradshaw JM. A simple index of crohn'sdisease activity. Lancet 1980;1:514.
33. Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut 1998;43:29-32.
34. Palmer KR. Complications of gastrointestinal endoscopy. Gut 2007;56:456-7.
35. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: Useful, magic, or unnecessary toys Gut 2006;55:426-31.
36. af Björkesten CG, Nieminen U, Turunen U, et al. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease. Scand J Gastroenterol 2012;47:528-37.
37. Jansson J, Willing B, Lucio M, et al. Metabolomics reveals metabolic biomarkers of crohn's disease. PLoS One 2009;4:e6386.
38. Tedjo DI, Smolinska A, Savelkoul PH, et al. The fecal Microbiota as a biomarker for disease activity in Crohn's disease. Sci Rep 2016;6:35216.
39. Rehman A, Rausch P, Wang J, et al. Geographical patterns of the standing and active human gut microbiome in health and IBD. Gut 2016;65:238-48.
40. Papa E, Docktor M, Smillie C, et al. Non-invasive mapping of the gastrointestinal Microbiota identifies children with inflammatory bowel disease. PLoS One 2012;7:e39242.
41. Bauer E, Zimmermann J, Baldini F, Thiele I, et al. BacArena: Individual-based metabolic modeling of heterogeneous microbes in complex communities. PLoS Comput Biol 2017;13:e1005544.